Product
Adebelizumab
1 clinical trial
1 indication
Indication
Small Cell Lung CancerClinical trial
A Single-arm, Multi-center and Exploratory Study of Adebelizumab Combined With Chemotherapy and Sequential Adebelizumab Combined With Radiotherapy in the Treatment of Newly Diagnosed Extensive Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2026-07-31